The NEUROMARK™ System is designed to treat symptoms of chronic rhinitis safely and effectively in the ENT physician’s office with a high degree of patient comfort. The system is engineered to gently apply controlled low-power Radio Frequency (RF) energy to target regions of the nasal cavity to disrupt the parasympathetic nerve signals and halt the inflammatory response, thereby eliminating core symptoms such as congestion and rhinorrhea. Using proprietary algorithms and biofeedback monitoring features, the intelligent system precisely delivers energy to the target nerve-dense region while restricting energy and minimizing damage to surrounding tissue and improving patient comfort.
Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases. The privately held, venture backed company is based in Galway Ireland. Neurent Medical was founded by CEO Brian Shields and CTO David Townley, culminating from their work at the BioInnovate Ireland program at the National University, Galway.
Co-founder & CEO
Co-founder & CTO
Chief Financial Officer
VP Strategic Marketing
Chairman of the Board
Former President, Medtronic Surgical Technologies
Partner & CFO,
Fountain Healthcare Partners
Stay up to date with the latest news from Neurent Medical
Neurent Medical Receives FDA Clearance for NEUROMARK™, a Novel Multi-Point Nerve Disruption Treatment for Chronic Rhinitis
18th November 2021
Neurent Medical Expands Leadership Team to Support Advancement of In-Office Chronic Rhinitis Treatment
24th June 2021
Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment
20th January 2021
14425 Falcon Head Blvd,
Bldg. E, Suite 100
Austin, TX 78738
This product is cleared by the FDA for use, but is currently not available for sale in the United States. Please contact us for further information.